Apollo Hospitals will leverage AI for Heart

New Delhi: Apollo Hospitals’ avowed aim of fighting against tsunami of Non Communicable Diseases (NCD) including cardiovascular disease has got a force multiplier in Microsoft. This partnership will lead to the prediction of the risk of cardiovascular disease in the Indian population.

As part of Microsoft’s AI Network for Healthcare initiative, Microsoft India and Apollo Hospitals Group have joined hands to set up a National Clinical Coordination Committee (NCCC) for AI-powered Cardiovascular Disease Risk Score API.

According to a press release NCCC will assist the core team at Apollo Hospitals and Microsoft by providing guidance on all cardiology and cardiovascular-related artificial intelligence projects; insights on developing clinical algorithm and treatment guidelines based on the inferences of national, multi-centre prospective study, a release said here.

‘The NCCC is a great step forward as part of our partnership with Apollo. We are also engaging global consortium partners to scale the AI-powered API (application programme interface),’ Microsoft, Cloud & Enterprise, Corporate Vice President, Anil Bhansali said,

‘We have already received approval for a pilot study and we hope that the findings will enable physicians to better understand the causes of CVDs in Indian population,’ he further said.

Speaking about the National Clinical Coordination Committee, Apollo Hospitals Group, Joint Managing Director, Sangita Reddy, said, ‘The NCCC will help us immensely in our fight against the rising tsunami of Non-Communicable Diseases (NCDs).’

According to the release, cardiovascular diseases (CVDs) are the biggest cause of mortality in India with nearly 25 percent mortalities in the age group of 25 to 69 years. The condition also seems to affect Indians at least a decade earlier as compared to the Europeans.

Given the high prevalence of CVDs among Indians, Apollo Hospitals and Microsoft India, in 2018, launched the first ever AI-powered CVD Risk Score API, designed specifically to predict the risk of cardiovascular disease in the Indian population, it said.

Built on Microsoft Azure, the API aims to determine a more accurate CVD risk score for the Indian population taking into consideration risk factors including lifestyle attribute like diet, tobacco and smoking preferences, physical activity and psychological stress and anxiety.

Related Posts

To Eat or not to Eat, if this Dilemma is ‘Eating’ you, ‘Eat’ this Book

New ‘Bible’ of Nearly ‘Ideal’ Eating hit stands to become Instant Best Seller New Delhi: You are a veritable Hamlet when it comes to the question, to eat or not…

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

Bharat Mandapam witnessed Spectacle of Crazy Innovations by Maker of Ssi Mantra, Best in class Surgical Robot New Delhi: It was a veritable display of innovative potential and prowess of…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Pak-made illegal cosmetics recovered from Itwari shop

Pak-made illegal cosmetics recovered from Itwari shop

Licences of 20 medical stores suspended after inspections

Licences of 20 medical stores suspended after inspections

Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

Bain Capital sells nearly 1 pc  stake in Emcure Pharma for Rs 289 crore

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

HP accounts for 47 inferior drugs in March alert

HP accounts for 47 inferior drugs in March alert